sorafenib has been researched along with phosphatidylcholines in 4 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 32,204 | 443 | 5,593 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yan, SJ; Zhang, FM; Zhang, H | 1 |
| Abel, T; Haralampiev, I; Herrmann, A; Huster, D; Luckner, M; Müller, P; Scheidt, HA | 1 |
| Aydin, Y; Dash, S; Heidari, Z; John, V; Omarova, M; Su, Y; Xuan, S; Yu, T; Zhang, D; Zhang, Y | 1 |
| Abu-Gharbieh, E; Abushawish, KYI; Al-Hroub, HM; Alzoubi, KH; Bustanji, Y; El-Huneidi, W; Elgendy, SM; Giddey, AD; Mousa, M; Omar, HA; Semreen, MH; Soares, NC; Soliman, SSM | 1 |
4 other study(ies) available for sorafenib and phosphatidylcholines
| Article | Year |
|---|---|
Preparation, in vitro release, and pharmacokinetics in rabbits of lyophilized injection of sorafenib solid lipid nanoparticles.
Topics: Animals; Benzenesulfonates; Chromatography, High Pressure Liquid; Fatty Acids; Female; Freeze Drying; Nanoparticles; Niacinamide; Particle Size; Phenylurea Compounds; Phosphatidylcholines; Powders; Pyridines; Rabbits; Sorafenib | 2012 |
The interaction of sorafenib and regorafenib with membranes is modulated by their lipid composition.
Topics: Antineoplastic Agents; Ascorbic Acid; Cell Membrane; Cell Membrane Permeability; Cholesterol; Dithionite; Kinetics; Niacinamide; Oxidation-Reduction; Phenylurea Compounds; Phosphatidylcholines; Phosphatidylethanolamines; Pyridines; Sorafenib; Spin Labels; Staining and Labeling; Unilamellar Liposomes | 2016 |
Amphiphilic Polypeptoids Rupture Vesicle Bilayers To Form Peptoid-Lipid Fragments Effective in Enhancing Hydrophobic Drug Delivery.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Carriers; Glycine max; Humans; Hydrophobic and Hydrophilic Interactions; Lipid Bilayers; Liposomes; Peptoids; Phosphatidylcholines; Protein Kinase Inhibitors; Sorafenib; Surface-Active Agents | 2019 |
Multi-Omics Analysis Revealed a Significant Alteration of Critical Metabolic Pathways Due to Sorafenib-Resistance in Hep3B Cell Lines.
Topics: Alanine; Amino Acids; Antineoplastic Agents; Biomarkers; Calpain; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Folic Acid Antagonists; Glucose; Humans; L-Iditol 2-Dehydrogenase; Liver Neoplasms; Metabolic Networks and Pathways; Nucleotides; Phosphatidylcholines; Proline; Protein Kinase Inhibitors; Proteome; Proteomics; Sorafenib; Succinic Acid; Superoxide Dismutase; Tyrosine; Ubiquitin Thiolesterase; Uridine Diphosphate | 2022 |